G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 12-2015 | |
| Operating Expenses | 0 | 6,613 | 7,429 | 0 |
| Operating Income | N/A | -6,613 | -7,429 | N/A |
| Other Income | 0 | 56 | 50 | 0 |
| Pre-tax Income | 0 | -6,557 | -7,379 | 0 |
| Net Income Continuous | N/A | -6,557 | -7,379 | N/A |
| Net Income | $N/A | $-6,557 | $-7,379 | $N/A |
| EPS Basic Total Ops | N/A | -5.21 | -5.63 | N/A |
| EPS Basic Continuous Ops | N/A | -4.40 | -4.97 | N/A |
| EPS Diluted Total Ops | N/A | -5.21 | -5.63 | N/A |
| EPS Diluted Continuous Ops | N/A | -4.40 | -4.97 | N/A |
| EBITDA(a) | $N/A | $-6,595 | $-7,429 | $N/A |